Reply to Monetti et al.: Hepatic steatosis and diacylglycerol-mediated hepatic insulin resistance in acyl-CoA:diacylglycerol acyltransferase 2 (DGAT2) transgenic mice

Similar Items

• Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1(−/−) mice
  od: Lee, Bonggi, i dr.
  Izdano: (2010)
• Activities of acyl-CoA:diacylglycerol acyltransferase (DGAT) and phospholipid:diacylglycerol acyltransferase (PDAT) in microsomal preparations of developing sunflower and safflower seeds
  od: Banaś, Walentyna, i dr.
  Izdano: (2013)
• Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
  od: Jornayvaz, François R., i dr.
  Izdano: (2011)
• Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases
  od: Cao, Jingsong, i dr.
  Izdano: (2011)
• Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity
  od: Monetti, Mara, i dr.
  Izdano: (2011)